Login
LB PHARMACEUTICALS INC logo

LB PHARMACEUTICALS INC

lbpharma.us

What Do They Do?

Develops an investigational medicine for people with schizophrenia and mood disorders.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −1561% (Loss)
vs −$3.6M in Q3 FY2025
  • Sep 3, 2026 Joseph Miller appointed chief financial officer

Who Do They Compete With?

Competes with HLS Therapeutics, AstraZeneca, Otsuka Pharmaceutical, Janssen Pharmaceuticals, Eli Lilly &, Sumitomo Pharma America, AbbVie, Vanda Pharmaceuticals, Teva Pharmaceutical Industries, Alkermes, Bristol-Myers Squibb, Alto Neuroscience, Minerva Neurosciences, MapLight Therapeutics, Neurocrine Biosciences, Reviva Pharmaceuticals Holdings, Acadia Pharmaceuticals, NRx Pharmaceuticals, Xenon Pharmaceuticals, and Axsome Therapeutics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support